🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

UNRWA posted on X that people claiming to be affiliated with Hamas seized fuel and medical equipment from their compound in Gaza City. The UN agency has since deleted that post. It is unclear why haaretz.com/israel-news/20…

Every day that passes we learn more about the atrocities committed against Israeli civilians by Hamas. We continue to investigate and gather information.

Read this amazing story of sacrifice. Reminds me so much of the stories we heard about the holocaust.

Immunotherapy pioneer Dr. Steven Rosenberg of NCI has been awarded the highest honor for technological achievement by President Donald J. Trump, the National Medal of Technology and Innovation, for his contributions to America’s economic, environmental, and social well-being spr.ly/6013uer7l

"I've killed ten jews with my own hands": A horrifying recording of a Hamas terrorist boasting to his parents of the massacre he took part in at a kibbutz. He made the call from the phone of one of the women he murdered

Would I have been one of the many Germans who was too scared to do anything but comply? Or worse: Would I have been one of people who was convinced by the hateful propaganda? Wonder no more, dear reader. Your moment is here. newsweek.com/left-empowerin…

“Everyone knew it when Marcel entered a room – she was a small woman with a huge presence”: Dr. Marcel Frailich Kaplun, who was murdered by Hamas terrorists on her kibbutz, was a passionate educator and a beloved figure at the Weizmann Institute of Science. Her colleagues bid her

Indeed. An inability to distinguish between terrorists trying to kill as many civilians as possible and a military operation against a terrorist force operating among civilians is a capitulation to barbarism. Mourn every innocent death, but do not confuse cause and effect.

Online Now: Phenotypic signatures of circulating neoantigen-reactive CD8+ T cells in patients with metastatic cancers dlvr.it/SzZvYb

Phenotypic signatures of circulating neoantigen-reactive CD8+ T cells in patients with metastatic cancers dlvr.it/T03K93

The first tumour-infiltrating lymphocyte (TIL) therapy for cancer could be approved by the FDA early next year, and a diverse pipeline of other TIL candidates is in development - find out more in our latest news article bit.ly/3NldJQE

Harnessing neoantigen-specific T cells for precision cancer immunotherapy 👉 NatureRevClinOncol, Jan 2024, free access link at rdcu.be/dwp89 💬 about "Phenotypic signatures of circulating neoantigen-reactive CD8+ T cells in patients with metastatic cancers" Rami Yoseph

Today, we approved the first cellular therapy indicated for treatment of adult patients with a type of skin cancer that is unable to be removed with surgery or has spread to other parts of the body that have previously been treated with other therapies. fda.gov/news-events/pr…

💥Great news! Patients with PD-1 refractory #melanoma have FDA Oncology approved #adoptive #immunotherapy option in #TIL/This treatment under development for >40 yrs (Rosenberg SA Sci 1986/NEJM 1988,Kradin R CII 1987) offers more hope to #FinishCancer Dr. Kimryn Rathmell Melanoma Research Foundation

Rosenberg, Restifo and team at the National Cancer Institute first described tumor infiltrating lymphocytes (TILs) as a living therapy. Now a new FDA therapy! nature.com/articles/d4158…

Lymphocytes as a living drug for cancer | Science science.org/doi/10.1126/sc…

JOB ALERT!!! Our division is hiring for a tenure track assistant professor position! Apply asap to join an amazing group of immunologists! Please report, like and apply! nature.com/naturecareers/…

I had the honor of presenting @NCIResearchCtr’s Dr. Steven Rosenberg with a milestone award for 50 years of excellent service to National Cancer Institute. His pioneering work in immunotherapy has touched lives, inspired researchers, and transformed our field. Congratulations, Steven!